Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
Pozycja w akcjach #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
Cena akcji
$0.83030862
Ostatnia synchronizacja: 2024-06-27
Kapitalizacja rynkowa
$726.64K
Zmiana (1 dzień)
-1.35%
Zmiana (1 rok)
0.00%
Kraj
DE
Handel Epigenomics AG (ECX)

Kategoria

Historia ceny akcji dla Epigenomics AG (ECX)
Najwyższa cena zamknięcia: $1.42 dnia 2024-06-01

Najniższa cena zamknięcia: $761.72 dnia 2014-09-01
Historia cen akcji firmy Epigenomics AG od 2014 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 -40.31%
2023 -70.25%
2022 -39.44%
2021 -83.30%
2020 -68.68%
2019 -24.83%
2018 -54.25%
2017 -3.39%
2016 90.76%
2015 -58.46%
2014 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$592.67 22.19%
US
$203.74 -3.08%
US
$23.08 67.91%
CN
$309.55 95.37%
US
$561.65 -14.11%
US